Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
https://doi.org/10.17650/1994-4098-2016-12-2-70-76
Abstract
The results of diagnostics of 65 patients with serous ovarian carcinoma are given in the article. Analysis of the investigation has allowed to include 13 patients (20 %) in the group 1 (low grade) and 52 (80 %) in the group 2 (high grade). According to the results of the executed work it is determined that the Immunocytochemical technique allows to verify ovarian carcinoma, differentiating it with carcinoma metastases of the other organs, that is very important for following treatment. In case of sufficient tumour cells in cytological specimens, specimens are valuable material for molecular-genetic researches. According to the results of genetic DNA investigations, suitable for the estimation, there was absence mutation of V600E in the BRAF-gene in all cases. The genetic mutation of KRAS-gene with 5 patients from the group1 (low grade) was noticed. Among them the genetic mutation of G12V was detected in 4 cases and mutation of G12D in 1 case. The mutations in the BRCA1-gene were
detected in 4 cases from the 2th group (high grade) three of them were presented by 5382insC mutation and one of them by T300G mutation. The usage of the multivariate analysis evaluating the cell composition of low and high grade carcinomas was allowed to distinguish the most significant features off ovarian carcinoma cells that will be allow to differentiate them by means of light microscopy.
About the Authors
O. G. Grigoruk
Altay branch of N.N. Blokhin Russian Cancer Research Center;
Altay Regional Oncology Dispensary
Russian Federation
Russian Federation
E. E. Pupkova
Altay Regional Oncology Dispensary
Russian Federation
Russian Federation
L. M. Bazulina
Altay Regional Oncology Dispensary
Russian Federation
Russian Federation
A. F. Lazarev
Altay branch of N.N. Blokhin Russian Cancer Research Center;
Altay Regional Oncology Dispensary
Russian Federation
Russian Federation
References
1. Аксель Е.М. Статистика злокачественных новообразований женской половой сферы. Онкогинекология 2012;(1):18–23. [Аksel’ Е.М. Statistics of malignant tumors of the female genital sphere. Onkoginekologiya = Оncogynecology 2012;(1):18–23. (In Russ.)].
2. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA. Cancer J Clin 2010;60:277–300.
3. Fleming J.S., Beaugie C.R., Haviv I. et al. Incessant ovulation, infl ammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 2006;247:4–21.
4. Жорданиа К.И., Хохлова С.В. Ранний рак яичников. Наш взгляд на проблему. Онкогинекология 2012(1):51–8. [Zhordania K.I., Khokhlovа S.V. Early ovarian cancer. Our view of the problem. Onkoginekologiya = Оncogynecology 2012(1):51–8. (In Russ.)].
5. Ожиганова И.Н. Морфология рака яичников в классификации ВОЗ 2013 года. Практическая онкология 2014;15(4):143–52. [Оzhiganovа I.N. Моrphology of the ovarian cancer in the WHO classification 2013. Prakticheskaya onkologiya = Practical Oncology 2014;15(4):143–52. (In Russ.)].
6. Жорданиа К.И., Паяниди Ю.Г., Калиничева Е.В. Два пути развития серозного рака яичников. Онкогинекология 2014;(3):42–8. [Zhordania K.I., Payanidi Yu.G., Kalinicheva E.V. Two ways of development of the serous ovarian cancer. Onkoginekologiya = Оncogynecology 2014;(3):42–8. (In Russ.)].
7. Нейштадт Э.Л., Ожиганова И.Н. Опухоли яичника. СПб.: Фолиант, 2014. 350 с. [Neyshtadt E.L., Ozhiganova I.N. Ovarian tumors. Saint Petersburg: Foliant, 2014. 350 p. (In Russ.)].
8. Heintz A.P., Odicino F., Maisonneuve P. et al. Carcinoma of the ovary FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95(Suppl 1):161–92.
9. Hennessy B.T., Coleman R.L., Markman M. Ovarian cancer. Lancet 2009;374:1371–82.
10. Kurman R.J., Visvanathan K., Roden R. et al. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol 2008;198:351–6.
11. Rubin S.C., Benjamin I., Behbakht K. et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Eng J Med 1996;335:1413–6.
12. Демидова И.А. Наследственно обусловленный рак яичников. Современная онкология 2015;17(3):70–5. [Demidova I.A. Inherited ovarian cancer. Sovremennaya onkologiya = Modern Oncology 2015;17(3):70–5. (In Russ.)].
13. Yang D., Khan S., Sun Y. et al. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA 2011;306(14):1557–65.
14. Kurman R.J., Ellenson L.H., Ronnett B.M. Blaustein’s pathology of the female genital tract. Sixth edition. Springer, 2011. 1252 p.
15. Kurman R.J., Сarcanqiu M.L., Herrington C.S., Young R.H. WHO Classificaihion of Tumours of Female Reproductive Organs. Fourth Edition. IARS: Lyon, 2014. 307 p.
16. Kobayashi Y., Terauchi F., Nishi H. et al. A case of advanced ovarian cancer upstaged on the bases of pleural washing cytology. J Obstet Gynaecol Res 2009;35(3):588–92.
17. Campos, S.M., Ghosh S. A current review of targeted therapeutics for ovarian cancer. J Oncol 2010;2010:149362. DOI: 10.1155/2010/149362.
18. Khan N., Afroz N., Aquil B. et al. Neoplastic and non-neoplastic ovarian masses. Diagnosis on cytology. J Cytol 2009;(26): 129–33.
19. Koss L.G., Melamed M.R. Tumours of the ovary and fallopian tube: In: Koss’ Diagnostic Cytology and its Histopatologic Bases. 5th ed. New York, Lippincott Williams &Wilkins, 2006. Р. 491–508.
20. Mathur S.R. Ovarian cancer: role of cytology. Indian J Med Paediatric Oncol 2007;27(1):5–6.
Review
For citations:
Grigoruk O.G., Pupkova E.E., Bazulina L.M., Lazarev A.F. Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics. Tumors of female reproductive system. 2016;12(2):70-76. (In Russ.) https://doi.org/10.17650/1994-4098-2016-12-2-70-76
Views:
1297
Email this article 